Search results
Results From The WOW.Com Content Network
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. [2] Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices.
Shares of Abiomed (ABMD) have been strong performers lately, with the stock up 43.1% over the past month. The stock hit a new 52-week high of $381.99 in the previous session.
Abiomed's (ABMD) latest regulatory clearance for the Impella Low Profile Sheath is expected to improve patient outcomes.
Abiomed, Inc. (NASDAQ:ABMD) is a company that conducts research, develops, and sells medical devices that help or take the place of a failing heart's pumping action. The company offers the Impella ...
Abiomed sells other pumps under the Impella brand, which are used for different therapeutic reasons. Johnson & Johnson struck a massive $16.6 billion all-cash deal in 2022 to buy Abiomed to boost ...
Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients suffering from COVID-19 ...
Continued adoption of Abiomed's (ABMD) Impella 5.5 with SmartAssist is likely to provide a minimally invasive surgical option for acute heart failure patients.
For premium support please call: 800-290-4726 more ways to reach us